Department of Psychology, Florida State University, FL, USA.
J Consult Clin Psychol. 2012 Oct;80(5):766-72. doi: 10.1037/a0027961. Epub 2012 Apr 2.
Anxiety disorders are the most prevalent psychiatric disorders in the United States and result in substantial burden to the individual and society. Although effective treatments for anxiety disorders have been developed, there has been substantially less focus on interventions aimed at the amelioration of anxiety-related risk and maintenance factors. Anxiety sensitivity (AS) is a well-established, malleable risk and maintenance factor for panic disorder and other psychopathology. The aim of the current investigation was to enhance the efficacy of AS treatment through the refinement of a previously validated intervention.
This 1-session intervention utilized psychoeducation and interoceptive exposure to target AS and was compared with a health-focused control intervention among a nontreatment seeking sample (N = 104) of individuals with elevated AS.
Study findings indicate that the active treatment group demonstrated significantly greater reductions in AS than the control group at posttreatment and across the 1-month study period. These treatment gains were seen across the ASI subscales. A Month 6 follow-up assessment indicated that the treatment group retained the majority of their AS reduction, whereas the control group retained their elevated AS scores. The intervention responses of participants meeting Axis I diagnostic criteria did not differ from the responses of those without a current diagnosis.
Despite the brevity of the treatment intervention, findings demonstrate that it resulted in substantial reductions in AS that were largely maintained 6 months posttreatment. Anxiety treatment and prevention implications are discussed.
焦虑障碍是美国最常见的精神障碍,给个人和社会带来了巨大负担。尽管已经开发出了有效的焦虑障碍治疗方法,但针对焦虑相关风险和维持因素的干预措施的关注要少得多。焦虑敏感(AS)是惊恐障碍和其他精神病理学的一个既定的、可改变的风险和维持因素。目前的研究旨在通过改进以前验证过的干预措施来提高 AS 治疗的效果。
该 1 次疗程的干预措施利用心理教育和内脏暴露来针对 AS,并与非治疗寻求样本(N = 104)中的健康为重点的对照组干预进行比较,这些个体具有升高的 AS。
研究结果表明,与对照组相比,活跃治疗组在治疗后和整个 1 个月的研究期间,AS 显著降低。这些治疗效果在 ASI 子量表中均可见。6 个月的随访评估表明,治疗组保留了大部分的 AS 减少,而对照组保留了升高的 AS 评分。符合轴 I 诊断标准的参与者的干预反应与没有当前诊断的参与者的反应没有差异。
尽管治疗干预措施的时间很短,但研究结果表明,它导致了 AS 的显著减少,这些减少在治疗后 6 个月内基本得到维持。讨论了焦虑治疗和预防的意义。